Premier Biomedical, Inc.
BIEI · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $1 | $1 |
| Gross Profit | $0 | $0 | -$1 | -$1 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $57 | $171 | $17 | $5 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $57 | $171 | $17 | $5 |
| Operating Income | -$57 | -$171 | -$18 | -$6 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$41 | -$31 | -$31 | -$32 |
| Pre-Tax Income | -$99 | -$202 | -$49 | -$39 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$99 | -$202 | -$49 | -$39 |
| % Margin | – | – | – | – |
| EPS | -0 | -0 | 0 | 0 |
| % Growth | 50% | – | – | – |
| EPS Diluted | -0 | -0 | 0 | 0 |
| Weighted Avg Shares Out | 1,098,879 | 1,098,880 | 1,098,880 | 999,981 |
| Weighted Avg Shares Out Dil | 1,098,879 | 1,098,880 | 1,098,880 | 999,981 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $41 | $31 | $31 | $32 |
| Depreciation & Amortization | $0 | $168 | $1 | $1 |
| EBITDA | -$57 | -$3 | -$17 | -$5 |
| % Margin | – | – | – | – |